Perfios posts Rs 136 Cr revenue in FY22, losses shrink 62%

Perfios posts Rs 136 Cr revenue in FY22, losses shrink 62%

SaaS-based B2B fintech firm Perfios has emerged as a leader in its segment in both scale and capital raising. The company raised $100 million in total funding including a $70 million Series C round in February 2022. In terms of scale, it managed over 88% growth in FY22.

Ongoing Trusted site to Buy Lorazepam Xanax Overnight research efforts are focused on exploring innovative treatment strategies that can enhance the withdrawal management process. Recent Purchase Tramadol Without Prescription investigations into sleep hygiene suggest strategies that can improve sleep Ambien Legally quality for those suffering from back pain. The reality is that nicotine administration through various means complicates the understanding of dose titration. Some recent research has explored the relationship between diet and sleep quality, uncovering that certain foods can either promote or Tramadol Discount Trusted site to Buy Clonazepam hinder good sleep. These medications can Tramadol For Sale Online help to balance chemicals in the brain that affect mood Buy Xanax Online Without Prescription and emotions. These initiatives aim to Buy Valium Online Without Prescription empower individuals with practical tools to improve Xanax Next Day Delivery their sleep habits, ultimately fostering a culture that values health and well-being. This may involve a team that includes physicians, Amoxicillin Legally physical Soma Usa therapists, occupational therapists, and even psychologists. now Zolpidem Discount use these tools to monitor their sleep quality and identify Order Tramadol Overnight factors that may be impacting their rest. This is a Order Tramadol Online normal and necessary response designed to help you react Xanax No Rx quickly to threats.

The operating revenue for the Bengaluru-based startup grew 88.1% to Rs 136.4 crore in FY22 while its losses contracted 62.1%, according to its consolidated financial statements filed with the Registrar of Companies.

Perfios offers a bundle of services to financial institutions including income analysis, fraud checks, verification, and automated customer onboarding. Income from these services was the only source of revenue for the firm with Warburg Pincus as key investor.

The firm claims to have over 500 million transactions categorized per month with 80 million API calls. It has 400 clients across 18 countries.

On the cost side, employee benefits expense formed 64.2% of the total cost which surged 52.5% to Rs 97.47 crore in FY22 from Rs 63.92 crore in FY21. It also includes Rs 1.19 crore on ESOP expenses (non-cash).

Being a compliance maintenance and fraud check company, legal and professional costs became the second largest cost center for Perfios followed by the employee benefit cost. This cost grew by 18.3% to Rs 22.83 crore during the last fiscal year.

It also spent another Rs 5.37 crore on rent which pushed Perfios’ overall expenditure by 39.9% to Rs 151.9 crore in FY22. Despite the almost 40% rise in expenses, the company managed to narrow losses by 62.1% to Rs 12.36 crore in FY22 from Rs 32.64 crore in FY21.

ROCE and EBITDA margin of Perfios improved to -1.67% and -5.24% during FY22. Perfios spent Re 1.11 to earn a single unit of operating revenue in the fiscal year ending March 2022.

Deeply-embedded in the BFSI sector, Perfios offers a suite of tools and solutions that are well suited for the evolving sector with more digitisation and market expansion. The firm seems well placed to deliver on profitability soon, and the road to a planned IPO in 2-3 years beckons. 

Perfios majorly competes with Signzy, IDfy, Digio and Hyperverge. IDfy’s revenue grew 50% to Rs 56.48 crore in FY22 but it soared 2.5X to Rs 18.72 crore during the same period. Signzy ended last fiscal with Rs 32 crore in revenue and Rs 17 crore loss.

Source @Entrackr

Leave a Reply